AQST
Aquestive Therapeutics, Inc. · Healthcare · Market cap $512.1M
Insiders sold $379K net in the last 90 days ·2 sellers, 0 buyers· 1 of 4 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 16, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.3M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Latest filing
Oct 16, 2026
Barber Daniel
Aquestive Therapeutics, Inc. (AQST) has 29 SEC Form 4 filings (39 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Oct 16, 2026.
Inside the rolling window, 8 insiders at Aquestive Therapeutics, Inc. reported no open-market purchases and 15 open-market sales totaling $2.3M. The most active filer is President and CEO Barber Daniel with 7 filings. Insiders have net sold $640K over the trailing 6 months. The most recent open-market filing is a sale of 25,000 shares by President and CEO Barber Daniel, dated Oct 15, 2026, worth $106K.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Daniel Barber
- Employees:147
- HQ:Warren, NJ, US
- IPO:2018-07-25
| Source | |||||||
|---|---|---|---|---|---|---|---|
| President and CEO | Sale | 25,000 | $106K | Oct 16 | +7.9% | SEC ↗ | |
| President and CEO | Sale | 25,000 | $120K | Sep 16 | -15.4% | SEC ↗ | |
Korczynski SherryFirst in 6 months | Chief Commercial Officer | Sale | 8,750 | $46K | Sep 11 | -14.6% | SEC ↗ |
| President and CEO | Sale | 25,000 | $107K | Aug 18 | -5.6% | SEC ↗ | |
| President and CEO | Sale | 4,631 | $19K | Jul 17 | -1.0% | SEC ↗ | |
| President and CEO | Sale | 20,369 | $82K | Jul 17 | -1.0% | SEC ↗ | |
Krop JulieFirst filing | Director | Sale | 25,000 | $125K | Jun 24 | -18.2% | SEC ↗ |
| President and CEO | Sale | 8,257 | $35K | May 18 | -1.3% | SEC ↗ | |
BRAENDER LORI JFirst filing | Chief Legal Officer | Sale | 40,102 | $167K | Mar 11 | -4.4% | SEC ↗ |
Boyd Peter E.First filing | Chief People Officer | Sale | 29,814 | $124K | Mar 11 | -4.4% | SEC ↗ |
Barber DanielFirst filing | President and CEO | Sale | 180,677 | $754K | Mar 11 | — | SEC ↗ |
Cioffi MelinaFirst filing | SVP, Regulatory Affairs | Sale | 25,311 | $106K | Mar 11 | — | SEC ↗ |
TOTH A ERNEST JRFirst filing | Chief Financial Officer | Sale | 58,254 | $243K | Mar 11 | — | SEC ↗ |
Jung CassieFirst filing | Chief Operating Officer | Sale | 45,791 | $191K | Mar 11 | — | SEC ↗ |
Korczynski SherryFirst filing | Chief Commercial Officer | Sale | 15,741 | $66K | Mar 11 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does AQST have?
Aquestive Therapeutics, Inc. (AQST) has 29 SEC Form 4 filings (39 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Oct 16, 2026.
When was the most recent SEC Form 4 filing for AQST?
The most recent Form 4 filing for AQST on Tracefour is dated Oct 16, 2026.
Who is the most active insider at AQST?
The most active SEC Form 4 filer at AQST in the rolling window is President and CEO Barber Daniel, with 7 filings.
What is the net insider flow at AQST over the last 6 months?
Over the trailing 180 days, insiders at AQST have net sold $640K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at AQST in the current window?
Inside the rolling window, insiders at AQST bought $0 and sold $2.3M based on SEC Form 4 filings.
Can I get alerts for AQST insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Aquestive Therapeutics, Inc. (AQST). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Aquestive Therapeutics, Inc. is in the Healthcare sector.